Emfo, LLC
- SEC CIK
- 0001859434
- Latest filing
- Jul 26, 2024
ATXI holding history
Avenue Therapeutics, Inc. in every 13F filed by Emfo, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ATXI overviewAll 13F holders of ATXIFull Q2 2024 holdings
- Shares (Q2 2024)
- 8
- Value
- $28
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 8 | $28 | <0.1% | −525−98.5% | Reduced | Holders |
| Q1 2024 | 533 | $79 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 533 | $86 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 533 | $377 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 533 | $624 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 533 | $621 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 533 | $618 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 533 | $5.00K | <0.1% | −534−50.0% | ReducedConverted for a 1-for-15 split | Holders |
| Q2 2022 | 16,000 | $4.00K | <0.1% | −8,000−33.3% | Reduced | Holders |
| Q1 2022 | 24,000 | $12.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 24,000 | $22.0K | <0.1% | −19,590−44.9% | Reduced | Holders |
| Q3 2021 | 43,590 | $65.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 43,590 | $109.0K | 0.1% | – | No prior filing | Holders |